首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

南美洲和中美洲临床试验市场预测至 2028 年 - 区域分析 - 按研究设计、阶段和适应症

市场调查报告书

商品编码

1402478

南美洲和中美洲临床试验市场预测至 2028 年 - 区域分析 - 按研究设计、阶段和适应症

South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design, Phase, and Indication

出版日期: 2023年10月26日 | 出版商:

The Insight Partners | 英文 125 Pages | 订单完成后即时交付

价格

简介目录图表

南美洲和中美洲临床试验市场预计将从2022年的17.9469亿美元增长到2028年的25.2398亿美元。预计2022年至2028年CAGR为5.8%。

分散临床试验和混合临床试验的采用推动了南美洲和中美洲临床试验市场

在分散临床试验 (DCT) 中，患者实际进入医院试验地点的机会被减少或消除。在 DCT 中，数位技术用于使患者能够参与临床研究、远端资料收集和监测以及研究人员和参与者之间的沟通。混合临床试验方法结合了家庭和现场活动，带来最佳的患者体验并满足复杂的方案製度，在各个治疗领域和试验阶段旅程中获得吸引力。最初，由于病患隐私、资料安全、监管障碍和复杂的协议制度等挑战，DCT的采用受到了影响。然而，由于COVID-19大流行，临床试验的申办者采用了分散和混合的临床技术来开发药物。他们无法继续进行传统试验，因为需要亲自拜访。由于旅行的限制，收集资料和继续试验的唯一方法是远端工作并比其他方式更快地采用技术。因此，权力下放扩大了试验范围，以涵盖更多数量且可能更多样化的患者群体。

此外，混合临床试验允许申办者策略性地将分散临床试验（DCT）元素纳入研究设计中。这些试验模型提供了前所未有的灵活性，因此更多的公司对混合试验感兴趣，由此产生的成长正在重新定义产业格局。据 ObvioHealth 称，FDA 计划在 2023 年推出支持 DCT 方法使用的方案，激发人们对这些成分用于未来临床研究的信心。因此，与传统临床试验方法相比，对使用分散和混合临床试验的日益关注预计将在预测期内为临床试验市场提供利润丰厚的机会。

南美洲和中美洲临床试验市场概述

南美洲和中美洲临床试验市场分为巴西、阿根廷以及南美洲和中美洲其他地区。南美洲和中美洲在临床试验市场中占据重要地位，预计在预测期内将出现强劲的成长率。这一增长是由于临床试验的不断增长、临床试验流程市场参与者的关键创新以及政府支持临床试验的倡议推动了市场的成长。

南美洲和中美洲临床试验市场收入及 2028 年预测（百万美元）

南美洲和中美洲临床试验市场细分

南美洲和中美洲临床试验市场分为阶段、研究设计、适应症和国家。

根据阶段，南美洲和中美洲临床试验市场分为 I 期、II 期、III 期和 IV 期。 2022 年，III 期细分市场在南美洲和中美洲临床试验市场占有率最大。

根据研究设计，南美洲和中美洲临床试验市场分为介入性、观察性和扩大访问。 2022 年，介入性细分市场占据南美洲和中美洲最大的临床试验市场。

根据适应症，南美洲和中美洲临床试验市场分为自体免疫/发炎、疼痛管理、肿瘤、中枢神经系统疾病、糖尿病、肥胖、心血管等。 2022 年，肿瘤学领域占据南美洲和中美洲最大的临床试验市场。

根据国家/地区，南美洲和中美洲临床试验市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，南美洲和中美洲其他地区主导了南美洲和中美洲临床试验市场份额。

Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、Laboratory Corp of America Holdings、Parexel International Corp、SGS SA、Syneos Health Inc 和 Thermo Fisher Scientific Inc. 是在南美洲和中美洲临床运营的一些领先公司试销市场。

In decentralized clinical trials (DCT), patients' physical access to hospital-based trial sites is reduced or eliminated. In DCTs, digital technologies are used to enable access of patients to clinical research, remote data collection and monitoring, and communication between investigators and participants. A hybrid clinical trial approach combines home-based and on-site activities, bringing the best patient experience and meeting complex protocol regimes, gaining traction across various therapeutic areas and trial phase journeys. Initially, due to challenges such as patient privacy, data security, regulatory barriers, and complex protocol regimes, the adoption of DCT was affected. However, due to the COVID-19 pandemic, the sponsors of clinical trials adopted decentralized and hybrid clinical techniques for developing drugs. They could not continue with traditional trials as they required in-person visits. Due to the restrictions for travel, the only way to gather data and keep trials going was to work remotely and adopt technology much faster than they would have otherwise. Therefore, decentralization broadens trial access to reach a larger number and potentially a more diverse pool of patients.

Further, hybrid clinical trials allow sponsors to strategically incorporate decentralized clinical trial (DCT) elements into study designs. These trial models offer unprecedented flexibility, so more companies are interested in hybrid trials, and the resulting growth is redefining the industry landscape. According to ObvioHealth, the FDA plans to unveil protocols in 2023 to support the use of DCT methods, inspiring confidence in these components for future clinical research. Thus, the increasing focus on using decentralized and hybrid clinical trials over traditional clinical trial methods is expected to provide lucrative opportunities for the clinical trials market during the forecast period.

South & Central America Clinical Trials Market Overview

The South & Central America clinical trials market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America occupies a significant position in the clinical trials market and is estimated to register a robust growth rate over the forecast period. The growth is due to growing clinical trials, key innovation by market players of clinical trial process, and government initiatives to support the clinical trial fuels the market growth.

South & Central America Clinical Trials Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Clinical Trials Market Segmentation

The South & Central America clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the South & Central America clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest South & Central America clinical trials market share in 2022.

Based on study design, the South & Central America clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest South & Central America clinical trials market share in 2022.

Based on indication, the South & Central America clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest South & Central America clinical trials market share in 2022.

Based on country, the South & Central America clinical trials market has been categorized into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America clinical trials market share in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Clinical Trials Market - By Phase
- 1.3.2 South & Central America Clinical Trials Market - By Study Design
- 1.3.3 South & Central America Clinical Trials Market - By Indication
- 1.3.4 South & Central America Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 South And Central America PEST Analysis
4.3 Experts Opinion

5. South & Central America Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - South & Central America Analysis

6.1 South & Central America Clinical Trials Market Revenue Forecast and Analysis

7. South & Central America Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Clinical Trials Market - By Phase

8.1 Overview
8.2 South & Central America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 South & Central America Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 Brazil: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Brazil: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Brazil: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 Brazil: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 Brazil: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 Argentina: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Argentina: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Argentina: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 Argentina: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 Argentina: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 Rest of South & Central America: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Rest of South & Central America: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Rest of South & Central America: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 Rest of South & Central America: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 Rest of South & Central America: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Charles River Laboratories International Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 ICON Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 SGS SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Syneos Health Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Thermo Fisher Scientific Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6
- 12.7.7 Key Developments
12.8 Laboratory Corp of America Holdings
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Brazil Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. Argentina Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. Rest of South & Central America Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of South & Central America Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of South & Central America Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms

List Of Figures

Figure 1. South & Central America Clinical Trials Market Segmentation
Figure 2. South & Central America Clinical Trials Market, By Region
Figure 3. South & Central America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in South & Central America Clinical Trials Market
Figure 5. Argentina is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South And Central America: PEST Analysis
Figure 7. South & Central America Experts Opinion
Figure 8. Impact Analysis
Figure 9. South & Central America Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. South & Central America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: South & Central America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Brazil: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Argentina: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of South & Central America: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)